2m 2m 2m 2m 2m 2m 2m
Corcept Therapeu (CORT)
NASDAQ
$116.19+$1.70 (+1.48%)
Price as of Aug 03, 2026 5:01 AM EDT- $12.3BMarket Cap
- 65.93%1-Year Change
- BiotechnologyIndustry
Corcept Therapeu (CORT)
$116.19+$1.70 (+1.48%)
CORT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $114.49 | ||
Change | -$3.83 (-3.24%) | ||
Open | $118.11 | ||
High | $118.53 | ||
Low | $111.79 | ||
Previous Close | $118.32 | ||
Volume | 1,841,139 | ||
30-Day Average Volume | 1,350,013 | ||
1-Week Change | 20.06% | ||
1-Month Change | 31.67% | ||
1-Year Change | 65.93% | ||
3-Year Change | 349.33% | ||
5-Year Change | 451.23% | ||
Fundamentals | |||
Shares Outstanding | 107.4M | ||
Total Assets | $888.7M | ||
Market Cap | $12.3B | ||
Enterprise Value | $12.2B | ||
Period: QTR TTM FY | |||
Revenue | $256.1M | ||
Net Income | $43.0M | ||
Free Cash Flow | $31.0M | ||
EBIT | $45.9M | ||
EBITDA | $46.8M | ||
Net Working Capital | $285.9M | ||
EPS | $0.36 | ||
Enterprise Value/EBITDA | 260 | ||
Enterprise Value/Revenue | 48 | ||
P/B | 17 | ||
P/E | 318 | ||
PEG | 1 | ||
Price/Free Cash Flow | 396 | ||
Price/Operating Cash Flow | 366 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue